Verano Holdings (VRNO) Net Cash Flow (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Net Cash Flow of -$8.7 million for Q1 2026, down 143.23% year-over-year from $20.1 million in Q1 2025, and down 8463.46% quarter-over-quarter from $104000.0 in Q4 2025.
Verano Holdings (VRNO) Net Cash Flow (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Net Cash Flow for 6 consecutive years, with -$8.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 143.23% year-over-year to -$8.7 million; the TTM figure through Mar 2026 stood at -$10.2 million (up 90.7% YoY), while the FY2025 annual figure was -$5.1 million, up 94.17% from the prior year.
- Net Cash Flow retreated to -$8.7 million in Q1 2026 per VRNO's latest filing, from $104000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $44.8 million in Q4 2023 and bottomed at -$65.1 million in Q3 2024.
- Historically, Net Cash Flow has averaged -$1.5 million across 5 years, with a median of $7.4 million in 2023.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 424.81% — and 2024, when it sank 955.78%.
- Verano Holdings' Net Cash Flow stood at $8.5 million in 2022, then soared by 424.81% to $44.8 million in 2023, then slumped by 49.13% to $22.8 million in 2024, then plunged by 99.54% to $104000.0 in 2025, then slumped by 8463.46% to -$8.7 million in 2026.
- Business Quant data shows VRNO's Net Cash Flow at -$8.7 million in Q1 2026, $104000.0 in Q4 2025, and $14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | - |
| 10 | Verano Holdings | 445.39 Mn | 360.20 Mn | 99.70 Mn | 11.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.17 Mn |
| Jun 30, 2026 | 11.17 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Dec 31, 2025 | 104,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 14.05 Mn |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | -15.65 Mn |
| Jun 30, 2025 | -15.65 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Dec 31, 2024 | 22.81 Mn |
| Dec 31, 2024 | 22.81 Mn |
| Sep 30, 2024 | -65.07 Mn |
| Sep 30, 2024 | -65.07 Mn |
| Jun 30, 2024 | -63.75 Mn |
| Jun 30, 2024 | -63.75 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Mar 31, 2024 | 19.02 Mn |